In summary, ceramide derived from sphingomyelin hydrolysis strongly promotes JNK activation and suppresses highly activated ERK during the early period of cerebral ischemia and reperfusion, which in turn, attenuates neuroprotective effects and results in ischemic lesions. This evidence concerns the gene MAPK8 and brain ischemia.